Unusual CNS presentation of thyroid cancer

被引:11
作者
Heery, Christopher R.
Engelhard, Herbert H. [2 ]
Slavin, Konstantin V. [2 ]
Michals, Edward A. [3 ]
Villano, J. Lee [1 ]
机构
[1] Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Neurosurg, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Radiol, Chicago, IL 60612 USA
关键词
Thyroid cancer; Brain tumor; Metastases; CNS; BRAIN METASTASES; PHASE-II; CARCINOMA; THERAPY; TRIAL;
D O I
10.1016/j.clineuro.2012.01.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
As advanced therapies allow cancer patients to live longer, disease failure in the central nervous system increases from limited therapeutic penetration. Primary thyroid malignancies rarely metastasize to the brain and have a small number of investigations in literature on the subject. The majority of brain metastases involve the brain parenchyma, reflecting the mass and blood distribution within the brain and central nervous system. Here, we report two cases of the most common differentiated thyroid cancers; follicular thyroid cancer having brain involvement from extra-axial growth and papillary thyroid cancer having brain involvement from a single intraventricular metastasis, presumed as metastasis from the vascular choroid plexus. Both of our cases had widespread systemic involvement. For our follicular thyroid cancer, brain involvement was a result of extra-axial growth from cavarial bone, and our papillary thyroid cancer had brain involvement from a single intraventricular metastasis that was initially resected and nearly a year later developed extensive brain involvement. Unlike the usual gray-white junction metastases seen in the majority of metastatic brain tumors, including thyroid, our cases are uncommon. They reflect differences in tumor biology that allows for spread and growth in the brain. Although there is growing genetic knowledge on tumors that favor brain metastases, little is known about tumors that rarely involve the brain. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1107 / 1109
页数:3
相关论文
共 18 条
  • [1] COMPARISON OF 2 METHODS OF PREVENTING CENTRAL NERVOUS-SYSTEM LEUKEMIA
    AUR, RJA
    HUSTU, HO
    VERZOSA, MS
    WOOD, A
    SIMONE, JV
    [J]. BLOOD, 1973, 42 (03) : 349 - 357
  • [2] Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
    Bible, Keith C.
    Suman, Vera J.
    Molina, Julian R.
    Smallridge, Robert C.
    Maples, William J.
    Menefee, Michael E.
    Rubin, Joseph
    Sideras, Kostandinos
    Morris, John C., III
    McIver, Bryan
    Burton, Jill K.
    Webster, Kevin P.
    Bieber, Carolyn
    Traynor, Anne M.
    Flynn, Patrick J.
    Goh, Boon Cher
    Tang, Hui
    Ivy, Susan Percy
    Erlichman, Charles
    [J]. LANCET ONCOLOGY, 2010, 11 (10) : 962 - 972
  • [3] Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
    Carr, Laurie L.
    Mankoff, David A.
    Goulart, Bernardo H.
    Eaton, Keith D.
    Capell, Peter T.
    Kell, Elizabeth M.
    Bauman, Julie E.
    Martins, Renato G.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (21) : 5260 - 5268
  • [4] Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting - Implications of the barriers between blood and brain
    de Lange, ECM
    Danhof, M
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (10) : 691 - 703
  • [5] DISTANT METASTASES IN PAPILLARY THYROID-CARCINOMA - 100 CASES OBSERVED AT ONE INSTITUTION DURING 5 DECADES
    DINNEEN, SF
    VALIMAKI, MJ
    BERGSTRALH, EJ
    GOELLNER, JR
    GORMAN, CA
    HAY, ID
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) : 2041 - 2045
  • [6] Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
    Gaspar, L
    Scott, C
    Rotman, M
    Asbell, S
    Phillips, T
    Wasserman, T
    McKenna, WG
    Byhardt, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04): : 745 - 751
  • [7] The Expression of Three Genes in Primary Non-Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain
    Grinberg-Rashi, Helena
    Ofek, Efrat
    Perelman, Marina
    Skarda, Jozef
    Yaron, Pnina
    Hajduch, Marian
    Jacob-Hirsch, Jasmin
    Amariglio, Ninette
    Krupsky, Meir
    Simansky, David A.
    Ram, Zvi
    Pfeffer, Raphael
    Galernter, Ilana
    Steinberg, David M.
    Ben-Dov, Issachar
    Rechavi, Gideon
    Izraeli, Shai
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (05) : 1755 - 1761
  • [8] CNS INVOLVEMENT IN SMALL NONCLEAVED-CELL LYMPHOMA - IS CNS DISEASE PER SE A POOR PROGNOSTIC SIGN
    HADDY, TB
    ADDE, MA
    MAGRATH, IT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) : 1973 - 1982
  • [9] Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
    Kloos, Richard T.
    Ringel, Matthew D.
    Knopp, Michael V.
    Hall, Nathan C.
    King, Mark
    Stevens, Robert
    Liang, Jiachao
    Wakely, Paul E., Jr.
    Vasko, Vasyl V.
    Saji, Motoyasu
    Rittenberry, Jennifer
    Wei, Lai
    Arbogast, Daria
    Collamore, Minden
    Wright, John J.
    Grever, Michael
    Shah, Manisha H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1675 - 1684
  • [10] Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: An effect of improved systemic therapy?
    Lin, C.
    Turner, S.
    Gurney, H.
    Peduto, A.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2008, 52 (04) : 376 - 381